Cresemba (isavuconazonium sulfate) - Astellas, Basilea
Noxafil (posaconazole) - Merck (MSD)
PROGNOSTIC ANALYSIS OF FUNGAL BLOODSTREAM INFECTIONS IN HEMATOLOGIC DISEASES BASED ON NGS (EHA 2026) - May 12, 2026 - Abstract #EHA-6183; PB4226; "Additionally, the therapeutic efficacy varied among different antifungal regimens, with superior outcomes observed in patients receiving amphotericin B monotherapy or combination therapy with amphotericin B plus isavuconazole/posaconazole. . 1. Analysis of the impact of cardiac insufficiency, concomitant bacterial infection, Mucorales infection, site of infection, gastrointestinal complications, and sex on prognosis in hematological patients with fever within 6 months" 
Next-generation sequencing • Bone Marrow Transplantation • Congestive Heart Failure • Gastroenterology • Heart Failure • Hematological Malignancies • Infectious Disease • Neutropenia
https://s3.eu-central-1.amazonaws.com/m-anage.com.storage.eha/temp/eha26_abstract/PB4226.pdf
 
Yingying MA 1; Ying Chen 1; Qin Wen 1; Xi Zhang 1; Cheng Zhang1
 
May 12, 2026
 
Prev Next